And, miR-141-3p was experimentally observed to be able to attenuate ferroptosis by regulating the Keap1-Nrf2 signaling pathway, which in turn promoted paclitaxel resistance in breast cancer cells. Here, NFE2L2 is linked to breast carcinoma.